Open AccessRisk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis
Author(s) -
Erica D. Dommasch,
Seoyoung C. Kim,
Moa P. Lee,
Joshua J. Gagne
Publication year - 2019
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2019.1121
Subject(s) - medicine , ustekinumab , infliximab , adalimumab , apremilast , etanercept , psoriasis , acitretin , psoriatic arthritis , dermatology , disease , rheumatoid arthritis
There is a need for better understanding of the comparative safety of systemic medications used in the treatment of psoriasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom